Indicate muscles, which are more resistant to block and recover more rapidly:

Questions 265

ATI RN

ATI RN Test Bank

Pharmacology Across the Lifespan Quizlet Questions

Question 1 of 5

Indicate muscles, which are more resistant to block and recover more rapidly:

Correct Answer: D

Rationale: In pharmacology, understanding the differential effects of drugs on various muscles is crucial. In the context of neuromuscular blocking agents, it is essential to know which muscles are more resistant to block and exhibit faster recovery. The correct answer is D) Diaphragm. The diaphragm is more resistant to neuromuscular blockade compared to other muscles because of its unique characteristics and high sensitivity to acetylcholine. The diaphragm's rapid recovery is attributed to its continuous and essential role in respiration, which demands quick restoration of function post-blockade. Option A) Hand, Option B) Leg, and Option C) Neck are not as resistant to block or quick to recover as the diaphragm. Muscles in the hand, leg, and neck are typically more sensitive to neuromuscular blockade due to differences in muscle fiber composition, innervation, and functional demands. Educationally, understanding the differential responses of muscles to pharmacological agents aids in clinical decision-making, especially in scenarios where precise control over muscle function is crucial, such as during surgery or mechanical ventilation. This knowledge ensures safe and effective administration of medications to optimize patient outcomes and prevent complications.

Question 2 of 5

Indicate the adrenomimetic agent, which is a beta₂ adrenoreceptor activator:

Correct Answer: A

Rationale: In this pharmacology quizlet question, the correct answer is A) Salbutamol. Salbutamol is an adrenomimetic agent that specifically activates beta₂ adrenoreceptors. Salbutamol is commonly used as a bronchodilator in conditions like asthma and chronic obstructive pulmonary disease (COPD). By activating beta₂ adrenoreceptors in the lungs, Salbutamol causes smooth muscle relaxation and bronchodilation, leading to improved airflow. Now, let's discuss why the other options are incorrect: B) Phenylephrine is an alpha₁ adrenoreceptor activator used as a decongestant and to increase blood pressure. It does not act on beta₂ receptors like Salbutamol. C) Clonidine is an alpha₂ adrenoreceptor agonist primarily used to treat hypertension and ADHD. It does not target beta₂ adrenoreceptors. D) Norepinephrine is a neurotransmitter and hormone that acts on both alpha and beta adrenoreceptors. However, it is not a selective beta₂ adrenoreceptor activator like Salbutamol. Understanding the specific receptor targets of different adrenomimetic agents is crucial in pharmacology across the lifespan. Knowing the mechanisms of action helps healthcare professionals make informed decisions when prescribing medications, ensuring safe and effective treatment for patients of all ages.

Question 3 of 5

Which of the following adverse effects is associated with administration of norepinephrine?

Correct Answer: B

Rationale: In pharmacology, it is crucial for learners to understand the potential adverse effects of medications to ensure safe and effective patient care. In the case of norepinephrine, which is a vasopressor used to treat hypotension and shock, the correct answer is B) Arrhythmias. Norepinephrine can increase heart rate and contractility, potentially leading to arrhythmias in some patients. Option A) Bronchospasm is incorrect because norepinephrine primarily affects cardiovascular function and does not have a direct effect on bronchial smooth muscle. Option C) Decrease in blood pressure is also incorrect as norepinephrine is used specifically to increase blood pressure in hypotensive states. Option D) Headache is incorrect as it is not a commonly reported adverse effect of norepinephrine. Educationally, understanding the adverse effects of norepinephrine is vital for healthcare professionals to monitor patients receiving this medication closely and intervene promptly if adverse reactions occur. This knowledge helps ensure patient safety and optimal treatment outcomes.

Question 4 of 5

Which of the following agents is an alpha₂-selective agonist with ability to promote constriction of the nasal mucosa?

Correct Answer: A

Rationale: In this question, the correct answer is A) Xylometazoline. Xylometazoline is an alpha₂-selective agonist that acts to constrict the nasal mucosa. This vasoconstriction helps in reducing nasal congestion by decreasing blood flow to the nasal mucosa, thereby relieving symptoms of stuffiness and congestion. This mechanism of action makes it a popular ingredient in nasal decongestant sprays and drops. Looking at the other options: B) Phenylephrine is also an alpha₁-selective agonist, but it is not as selective for alpha₂ receptors as xylometazoline, making it less effective in promoting constriction of the nasal mucosa. C) Methoxamine is an alpha₁-selective agonist, which does not have the same mechanism of action as xylometazoline in promoting nasal constriction. D) Epinephrine is a non-selective adrenergic agonist, which means it acts on both alpha and beta receptors and does not specifically target the alpha₂ receptors involved in nasal constriction. Understanding the differences in the selectivity of adrenergic agonists is crucial in pharmacology as it helps healthcare providers choose the most appropriate medication for specific conditions. Knowing the specific actions of each drug aids in optimizing treatment outcomes and minimizing side effects.

Question 5 of 5

Which of the following sympathomimetics is related to short-acting topical decongestant agents?

Correct Answer: C

Rationale: In pharmacology, it is crucial for students to understand the mechanisms of action of different sympathomimetic agents to make informed clinical decisions. In this case, the correct answer is C) Phenylephrine. Phenylephrine is related to short-acting topical decongestant agents because it acts as an alpha-1 adrenergic agonist, causing vasoconstriction in nasal mucosa, which leads to reduced swelling and congestion. Now, let's analyze why the other options are incorrect: A) Xylometazoline: While xylometazoline is also a topical decongestant agent, it is not a sympathomimetic drug. It works by directly constricting blood vessels in the nasal passages. B) Terbutaline: Terbutaline is a beta-2 adrenergic agonist commonly used as a bronchodilator in conditions like asthma and COPD, not as a decongestant. D) Norepinephrine: Norepinephrine is a neurotransmitter and a sympathomimetic agent, but it is not commonly used as a topical decongestant due to its short duration of action and potential for systemic side effects. Educationally, understanding the specific mechanisms of action of sympathomimetic agents helps students differentiate between various drug classes and their clinical applications. It also reinforces the importance of selecting the most appropriate medication based on the desired therapeutic effect.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions